
INOVIO to Highlight Breakthrough Immunotherapy Data at AACR Conference
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has announced that new research on its investigational immunotherapy, INO-3107, will be presented at the American Association for Cancer Research – Immuno-Oncology conference from …
INOVIO to Highlight Breakthrough Immunotherapy Data at AACR Conference Read More